相关实验视频

Updated: Jun 4, 2026

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

整合门德尔随机分析以确定因果性血蛋白和神经的治疗点

Ruijinlin Hao¹, Ningwei Su², Yin Fang¹

¹Department of Anesthesiology, the First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China.

Progress in neuro-psychopharmacology & biological psychiatry

|August 23, 2025

概括

这项研究使用孟德尔的随机化方法发现与妄想有关的血蛋白质,确定治疗和预防的潜在新药标.

科学领域:

基因组学
蛋白质组学
神经科学

背景情况:

妄是一种常见且严重的疾病,
确定病因因素和治疗目标对于改善患者的结果至关重要.

研究的目的:

为了确定与妄想相关的循环蛋白质.
发现新型药物用于预防和治疗妄想症.

主要方法:

使用大规模的双样本门德尔随机化 (MR) 来分析数千个血蛋白.
使用贝叶斯定位,施泰格过和eQTL-pQTL映射进行强有力的因果推断.
进行网络分析 (PPI) 和路径丰富,以了解生物机制.

主要成果:

鉴定出几种血蛋白对妄有显著的因果作用.
证实了共同的遗传结构, 并证实了因果关系的方向.
揭示了神经炎症和大脑功能途径的参与.
突出了特定的蛋白质作为潜在的治疗点.

结论:

几种血蛋白与妄想有因果关系,作为潜在的生物标志物和治疗点.
这项研究使用先进的生物信息学为这些关联提供了有力的证据.
这些发现有助于我们更好地了解妄想症的分子基础,

关键词:

狂妄症孟德尔随机化血蛋白质治疗目标

更多相关视频

Systems Analysis of the Neuroinflammatory and Hemodynamic Response to Traumatic Brain Injury

Systems Analysis of the Neuroinflammatory and Hemodynamic Response to Traumatic Brain Injury

Published on: May 27, 2022

Quantitative Proteomics Workflow using Multiple Reaction Monitoring Based Detection of Proteins from Human Brain Tissue

Quantitative Proteomics Workflow using Multiple Reaction Monitoring Based Detection of Proteins from Human Brain Tissue

Published on: August 28, 2021

相关概念视频

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...